Literature DB >> 32215908

Muscone suppresses inflammatory responses and neuronal damage in a rat model of cervical spondylotic myelopathy by regulating Drp1-dependent mitochondrial fission.

Long-Yun Zhou1,2,3, Min Yao1,2, Zi-Rui Tian1,2, Shu-Fen Liu1,2, Yong-Jia Song1,2, Jie Ye4, Gan Li1,2, Yue-Li Sun1,2, Xue-Jun Cui1,2, Yong-Jun Wang1,2.   

Abstract

Cervical spondylotic myelopathy (CSM) is a common cause of disability with few treatments. Aberrant mitochondrial dynamics play a crucial role in the pathogenesis of various neurodegenerative diseases. Thus, regulation of mitochondrial dynamics may offer therapeutic benefit for the treatment of CSM. Muscone, the active ingredient of an odoriferous animal product, exhibits anti-inflammatory and neuroprotective effects for which the underlying mechanisms remain obscure. We hypothesized that muscone might ameliorate inflammatory responses and neuronal damage by regulating mitochondrial dynamics. To this end, the effects of muscone on a rat model of chronic cervical cord compression, as well as activated BV2 cells and injured neurons, were assessed. The results showed that muscone intervention improved motor function compared with vehicle-treated rats. Indeed, muscone attenuated pro-inflammatory cytokine expression, neuronal-apoptosis indicators in the lesion area, and activation of the nod-like receptor family pyrin domain-containing 3 inflammasome, nuclear transcription factor-κB, and dynamin-related protein 1 in Iba1- and βIII-tubulin-labeled cells. Compared with vehicle-treated rats, compression sites of muscone-treated animals exhibited elongated mitochondrial morphologies in individual cell types and reduced reactive oxygen species. In vitro results indicated that muscone suppressed microglial activation and neuronal damage by regulating related-inflammatory or apoptotic molecules. Moreover, muscone inhibited dynamin-related protein 1 activation in activated BV2 cells and injured neurons, whereby it rescued mitochondrial fragmentation and reactive oxygen species production, which regulate a wide range of inflammatory and apoptotic molecules. Our findings reveal that muscone attenuates neuroinflammation and neuronal damage in rats with chronic cervical cord compression by regulating mitochondrial fission events, suggesting its promise for CSM therapy.
© 2020 International Society for Neurochemistry.

Entities:  

Keywords:  Drp1; NLRP3 inflammasome; cervical spondylotic myelopathy; mitochondrial dynamics; muscone

Year:  2020        PMID: 32215908     DOI: 10.1111/jnc.15011

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  Shikonin inhibits neuronal apoptosis via regulating endoplasmic reticulum stress in the rat model of double-level chronic cervical cord compression.

Authors:  Min Yao; Gan Li; Long-Yun Zhou; Zhong Zheng; Yue-Li Sun; Shu-Fen Liu; Yong-Jun Wang; Xue-Jun Cui
Journal:  Cell Biol Toxicol       Date:  2022-01-14       Impact factor: 6.691

Review 2.  Muscone Can Improve Spinal Cord Injury by Activating the Angiogenin/Plexin-B2 Axis.

Authors:  Yu Zhou; Shitian Guo; Benson O A Botchway; Yong Zhang; Tian Jin; Xuehong Liu
Journal:  Mol Neurobiol       Date:  2022-07-09       Impact factor: 5.682

3.  Muscone improves hypoxia/reoxygenation (H/R)-induced neuronal injury by blocking HMGB1/TLR4/NF-κB pathway via modulating microRNA-142.

Authors:  Weihua Ren; Fucheng Zhao; Yanru Han; Zhenzhou Liu; Jianli Zhai; Kui Jia
Journal:  PeerJ       Date:  2022-07-15       Impact factor: 3.061

4.  Cacna2d2 inhibits axonal regeneration following surgical decompression in a rat model of cervical spondylotic myelopathy.

Authors:  Peisheng Liu; Xiaofeng Li; Jing Liu; Hengjia Zhang; Zhitao You; Jianfeng Zhang
Journal:  BMC Neurosci       Date:  2022-07-01       Impact factor: 3.264

5.  Predictive Nomogram for Clinical Prognosis in Cervical Spondylotic Myelopathy With Intramedullary T2-Weighted Increased Signal Intensity: A Novel Digital Tool for Patient Prognosis Education.

Authors:  Jie Wang; Haopeng Li; Baohui Yang
Journal:  Front Public Health       Date:  2022-05-31

6.  Musk (Moschus moschiferus) Attenuates Changes in Main Olfactory Bulb of Depressed Mice: Behavioral, Biochemical, and Histopathological Evidence.

Authors:  Hailah M Almohaimeed; Ashwaq H Batawi; Zuhair M Mohammedsaleh; Soad Al Jaouni; Samiah A Mutlq Alsawat; Manal G Abd El Wahab; Amany A AbdElfattah; Nasra N Ayuob
Journal:  Front Behav Neurosci       Date:  2021-08-27       Impact factor: 3.558

7.  From non-targeted to targeted GC-MS metabolomics strategy for identification of TCM preparations containing natural and artificial musk.

Authors:  Meng Ding; Jun-Li Fan; Dong-Fang Huang; Yue Jiang; Meng-Ning Li; Yu-Qing Zheng; Xiao-Ping Yang; Ping Li; Hua Yang
Journal:  Chin Med       Date:  2022-04-01       Impact factor: 5.455

8.  TXNIP Participated in NLRP3-Mediated Inflammation in a Rat Model of Cervical Spondylotic Myelopathy.

Authors:  Peisheng Liu; Xiaofeng Li; Jing Liu; Hengjia Zhang; Zhitao You; Jianfeng Zhang
Journal:  J Inflamm Res       Date:  2022-08-09

9.  NLRP-3 Inflammasome: A Key Target, but Mostly Overlooked following SARS-CoV-2 Infection.

Authors:  Consolato M Sergi
Journal:  Vaccines (Basel)       Date:  2022-08-12

Review 10.  Zoology, chemical composition, pharmacology, quality control and future perspective of Musk (Moschus): a review.

Authors:  Kai Liu; Long Xie; Mao Deng; Xumin Zhang; Jia Luo; Xiaofang Li
Journal:  Chin Med       Date:  2021-06-19       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.